Hikma Pharmaceuticals Share News (HIK)

TOP NEWS: Hikma Reiterates Guidance For 2016 On Good Start

AGM, EGM Calendar - Week Ahead

Director dealings: Hikma gets shot in the arm as chief tops up

(ShareCast News) - Hikma Pharmaceuticals's chief Said Darwazah boosted his stake in the generic drugs firm on Wednesday to 5.49% through the acquisition of 30,000 shares at an individual price of 2,271p. The transaction was carried out by Vidacos Nominees on behalf of Darhold Limited, in which Darwa

Director dealing: Hikma directors keep buying

(ShareCast News) - Hikma Pharmaceuticals' newest board member has bought himself some skin in the game, following his chief executive's lead. US public affairs veteran John Castellani, who was appointed to the board in February, spent around £53,000 buying 2,500 shares at a price of 2,103p apiece.

DIRECTOR DEALINGS: Hikma Non-Executive Director Buys First Shares

LONDON MARKET CLOSE: Oil Rally Helps FTSE 100 To Highest 2016 Close

LONDON MARKET MIDDAY: "Risky" Oil Price Rally Supports Stocks

WINNERS & LOSERS SUMMARY: Pathfinder Sinks After Mozambique Ruling

Hikma filing for generic of Glaxo's Advair Diskus accepted by US FDA

(ShareCast News) - Hikma Pharmaceuticals said on Friday that its abbreviated new drug application for fluticasone propionate and salmeterol inhalation powder has been accepted for filing by the Food and Drug Administration in the US. The product is the generic version of GlaxoSmithKline's Advair Dis

LONDON MARKET OPEN: Resource Stocks Lead Gainers As Oil Recovers

US Accepts Hikma, Vectura Filing For Generic Of Glaxo's Advair Diskus

London-listed pharmas rally as Pfizer-Allergan deal collapses

(ShareCast News) - Shares in pharmaceuticals companies Shire, AstraZeneca and GlaxoSmithKline rallied on Wednesday as investors bet that the termination of Pfizer's agreement to buy Allergan might make the London-listed companies bid targets. US drug maker Pfizer said on Wednesday that its $160bn ag

Director dealings: Hikma boss buys £600K worth of shares

(ShareCast News) - The chairman and chief executive of Hikma Pharmaceuticals has purchased more than £600,000 worth of shares in the drugmaker. Said Darwazah bought 30,000 shares for 2,055.00p each, totalling £616,499.98 JP Morgan on Wednesday reiterated its 'overweight' rating on the stock and set

DIRECTOR DEALINGS: Hikma Chief Darwazah Builds Stake Through Darhold

Dividends Calendar - Week Ahead